National Health Investors (NHI) Scheduled to Post Quarterly Earnings on Monday

National Health Investors (NYSE:NHI) is set to release its earnings data after the market closes on Monday, May 6th. Analysts expect National Health Investors to post earnings of $1.06 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

National Health Investors Stock Performance

NYSE NHI opened at $64.72 on Friday. The firm has a market cap of $2.81 billion, a price-to-earnings ratio of 20.68 and a beta of 0.95. The company has a 50-day simple moving average of $60.55 and a two-hundred day simple moving average of $56.17. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90. National Health Investors has a 12-month low of $47.54 and a 12-month high of $65.23.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, May 3rd. Investors of record on Thursday, March 28th were issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 5.56%. The ex-dividend date was Wednesday, March 27th. National Health Investors’s dividend payout ratio is presently 115.02%.

Insider Transactions at National Health Investors

In other news, Director Charlotte A. Swafford bought 10,000 shares of the stock in a transaction dated Tuesday, February 27th. The stock was bought at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the purchase, the director now directly owns 110,185 shares in the company, valued at approximately $6,466,757.65. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 7.26% of the company’s stock.

Analyst Ratings Changes

NHI has been the subject of several recent research reports. BMO Capital Markets upgraded National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price objective for the company in a research report on Tuesday, March 12th. Wedbush boosted their price objective on shares of National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a research report on Monday, March 18th. Wells Fargo & Company upgraded shares of National Health Investors from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $55.00 to $63.00 in a report on Monday, February 26th. Deutsche Bank Aktiengesellschaft started coverage on National Health Investors in a report on Tuesday, January 30th. They set a “buy” rating and a $69.00 price target on the stock. Finally, Truist Financial increased their price objective on National Health Investors from $55.00 to $58.00 and gave the stock a “hold” rating in a report on Thursday, April 4th. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $60.50.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.